Table 1A: Doses to the heart and lungs: Absolute volumes for doses (V5 = Volume that receives 5Gy etc) and relative volumes (%) are given for patient A and patient B. Relevant measurable values of doses to OAR are nearly halfened by DIBH vs. FB in patient A. In patient B there is a visible reduction of lower lung doses (V5) that might be relevant in terms of RP protection.

Technique Volume Mean V5 V25
dose
[ml] [Gy] [%] [ml] [%] [ml]
Heart (FB) A 708 17.5 90.8 643 24.7 175
Heart (DIBH) A 611 6.2 36.9 225 5.2 32
Heart (FB) B 571 10.8 54.3 310 16.2 93
Heart (DIBH) B 513 11.1 52.8 271 16.9 87
Technique Volume Mean V5 V10 V20 V30
dose
[ml] [Gy] [%] [ml] [%] [ml] [%] [ml] [%] [ml]
Left Lung (FB) A 1451 14.0 78.2 1135 39.5 573 23.9 347 16.9 245
Right Lung (FB) A 1720 13.8 76.7 1319 39.5 679 22.7 390 15.6 268
Left Lung (DIBH) A 2946 8.0 43.9 1293 22.8 672 12.6 371 8.3 245
Right Lung (DIBH) A 3316 8.4 51.2 1698 24.2 802 12.1 401 7.3 242
Left Lung (FB) B 1903 7.7 47.3 900 26.2 499 10.0 190 4.0 76
Right Lung (FB) B 2038 10.2 73.5 1498 35.4 721 11.8 240 5.5 112
Left Lung (DIBH) B 3319 6.8 43.7 1450 20.9 694 9.5 315 4.0 133
Right Lung (DIBH) B 3359 9.2 65.4 2197 33.5 1125 10.5 353 4.6 155